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ABSTRACT
Background GATA zinc ﬁnger domain containing 2B
(GATAD2B) encodes a subunit of the MeCP1-Mi-2/
nucleosome remodelling and deacetylase complex
involved in chromatin modiﬁcation and regulation of
transcription. We recently identiﬁed two de novo loss-of-
function mutations in GATAD2B by whole exome
sequencing in two unrelated individuals with severe
intellectual disability.
Methods To identify additional individuals with
GATAD2B aberrations, we searched for microdeletions
overlapping with GATAD2B in inhouse and international
databases, and performed targeted Sanger sequencing
of the GATAD2B locus in a selected cohort of 80
individuals based on an overlap with the clinical features
in the two index cases. To address whether GATAD2B is
required directly in neurones for cognition and neuronal
development, we investigated the role of Drosophila
GATAD2B orthologue simjang (simj) in learning and
synaptic connectivity.
Results We identiﬁed a third individual with a 240 kb
microdeletion encompassing GATAD2B and a fourth
unrelated individual with GATAD2B loss-of-function
mutation. Detailed clinical description showed that all
four individuals with a GATAD2B aberration had a
distinctive phenotype with childhood hypotonia, severe
intellectual disability, limited speech, tubular shaped
nose with broad nasal tip, short philtrum, sparse hair
and strabismus. Neuronal knockdown of Drosophila
GATAD2B orthologue, simj, resulted in impaired learning
and altered synapse morphology.
Conclusions We hereby deﬁne a novel clinically
recognisable intellectual disability syndrome caused by
loss-of-function of GATAD2B. Our results in Drosophila
suggest that GATAD2B is required directly in neurones
for normal cognitive performance and synapse
development.
INTRODUCTION
Intellectual disability (ID) is a group of disorders
with an extremely heterogeneous clinical and
genetic presentation. More than 500 ID genes have
been identiﬁed and many more await discovery.
This large number of ID genes is believed to con-
verge onto a limited number of common under-
lying pathways and processes.1 Several ID genes
encode proteins that are involved in chromatin
modiﬁcation.1 2
Since the recent advent of next generation
sequencing technology, whole exome sequencing
(WES) has been successfully applied to the identiﬁ-
cation of genes for clinically established ID syn-
dromes.3–6 In addition, family based WES was
successful in elucidating causative de novo gene
mutations in sporadic individuals who do not
present with a recognisable syndrome.7–9 However,
exploration of the pathogenicity of mutations in
genes not previously associated with ID remains
challenging. To establish a conclusive molecular
diagnosis, it is therefore required to detect muta-
tions in the same candidate genes in additional indi-
viduals with similar phenotype.10 Moreover,
additional evidence and insights into functional
properties of novel genes are desirable and can be
obtained through studies in cell or animal models.
By application of trio based WES, we recently
reported the identiﬁcation of 22 candidate genes for
ID.8 Among these was the GATA zinc ﬁnger domain
containing 2B (GATAD2B) gene (NM_020699.2). In
this gene, we identiﬁed two loss-of-function mutations
in two unrelated individuals (c.584dupT; p.(Asn195fs)
and c.1408 C>T; p.(Gln470*)). GATAD2B encodes
p66beta, a subunit of the transcription repressor
complex MeCP1-Mi-2/nucleosome remodelling and
deacetylase (NuRD), responsible for silencing of
methylated DNA by nucleosome remodelling and
histone deacetylation.11 12
Here, we report an additional individual with a
disruptive GATAD2B mutation (c.565_566del; p.
(Gln190fs)), representing the third loss-of-function
mutation in this gene. The mutation was revealed
by direct Sanger sequencing in a selected cohort of
80 individuals with overlapping features comprising
ID, childhood hypotonia and an abnormal shape of
the nose (including a tubular shape, prominent and
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broad base of the nose). In addition, we found a fourth individ-
ual with a 240 kb de novo microdeletion encompassing
GATAD2B. Comparison of the phenotype of all four individuals
revealed a remarkable overlap in clinical presentation.
Modelling of the Drosophila orthologue of GATAD2B
loss-of-function conﬁrms its role in cognition and shows a crit-
ical role of GATAD2B in synapse development. Together, our
data establish a novel ID syndrome. It adds to the growing list
of ID conditions that are caused by mutated genes involved in
chromatin remodelling that can shed light onto the epigenetic
control of cognition.
METHODS
Patients
Individuals 1 and 2 were ascertained through family based WES
studies recently reported by our group7 8 (trio 4 in Vissers et al7
and trio 69 in Ligt et al8 respectively). The GATAD2B mutation in
individual 1 was noticed in retrospect upon reanalysis of the
sequencing data, after the detection of the mutation in individual 2.
Subsequently, we searched for individuals with small microde-
letions overlapping with GATAD2B in our inhouse database and
international databases, including the database of the European
Cytogeneticists Association Register of Unbalanced Chromosome
Aberrations (ECARUCA) and the Database of Chromosomal
Imbalance and Phenotype in Humans using Ensembl Resources
(Decipher).
In addition, we selected a cohort of 80 individuals guided by
phenotypic overlap with individuals 1 and 2. This cohort was
selected based on the presence of severe ID (IQ ≤50), limited
speech ability, childhood hypotonia and facial features including
abnormal shaped nose (large/prominent nose, full nose tip,
tubular shaped/pear-shaped nose, broad base of the nose). All
individuals had been referred to the Department of Human
Genetics of the Radboud University Medical Centre in
Nijmegen, the Netherlands, for genetic diagnostic evaluation of
unexplained ID/developmental delay. Their parents/legal repre-
sentatives consented to this study. The study was approved by
the local ethical committee.
Mutation screening
Targeted Sanger sequencing of GATAD2B (NM_020699.2) was
performed using standardised methods. Primers are available
upon request. The mutation in individual 4 and the low grade
mosaic in her mother were conﬁrmed with a second independ-
ent primer pair.
Fly stocks and maintenance
Fly stocks were kept on standard Drosophila diet (cornmeal/
sugar/yeast) at 25°C and 45%–60% humidity at 12 h light–dark
cycle. Flies were reared at 25°C, 70% humidity for habituation
experiments and real-time PCR, and at 28°C, 60% humidity to
evaluate synapse morphology. Simjang (Simj) (CG32067) is the
Drosophila orthologue of GATAD2B (Ensemble, see also Results
section). An inducible RNA interference (RNAi) line against
simj (vdrcKK100285, a line with the highest speciﬁcity score,
s19=1) and its corresponding control line (vdrcKK60100) were
obtained from Vienna Drosophila RNAi Center (http://www.
vdrc.at). RNAi was induced by the UAS-Gal4 system using a
panneuronal elav-Gal4 driver or a ubiquitous actin-Gal4 driver
obtained from the Drosophila Bloomington Stock Center
(http://ﬂystocks.bio.indiana.edu/). Line w1118; 2xGMR-wIR;
elav-Gal4, UAS-Dicer2 used in habituation experiments was pro-
duced by recombination of two independent insertions of
GMR-wIR on chromosome II and recombination of one copy of
elav-Gal4 and UAS-Dicer2 insertions on chromosome III. The
w1118; UAS-Dicer2; elav-Gal4 driver was used to study synapse
morphology, and a w1118; actin-Gal4/CyOGFP driver to gener-
ate homogeneous knockdown material for real-time PCR.
Light-off jump reﬂex habituation
The light-off jump reﬂex habituation assay was performed as
previously described13 with minor adaptations to the protocol.
Brieﬂy, 3–7-day-old individual male ﬂies were tested for jump
response in two independent 16-unit light-off jump reﬂex
habituation systems. A total of 32 ﬂies (16-ﬂies/system) were
simultaneously exposed to series of 100 short (15 ms) light-off
pulses with a 1 s interval between the pulses. The noise ampli-
tude of wing vibration following every jump response was
recorded for 500 ms after the start of pulse and a carefully
chosen threshold was applied to distinguish the jump response.
Data were collected and analysed by custom-made Labview
Software (National Instruments). High initial jumping response
to light-off pulse decreased with growing number of trials and
ﬂies were considered habituated when they failed to jump in
ﬁve consecutive trials (non-jump criterion). Habituation was
scored as the number of trials required to reach the non-jump
criterion (Trials To Criterion (TTC)). Mean TTC values of eight
independent groups of 16 ﬂies (tested on four different days)
were compared with mean TTC values of control ﬂies using
one-way Analysis of variance (ANOVA) with correction for dif-
ferent experimental day and system.
Drosophila synapse morphology
Type 1b neuromuscular junctions (NMJs) at muscle 4 were ana-
lysed after dissection of L3 larvae and ﬁxation in 3.7% parafor-
maldehyde (PFA) for 30 min. Preparations were colabelled for
bruchpilot (brp) and discs large 1 (dlg1). Brp was visualised
using the primary antibody nc82 (1 : 125) (Developmental
Studies Hybridoma Bank, University of Iowa) applied overnight
at 4°C, and a secondary Alexa 488-labelled goat-antimouse anti-
body (1 : 500) (Invitrogen). Discs large was visualised using the
primary antibody anti-dlg1 (1 : 25) (Developmental Studies
Hybridoma Bank) in combination with the Zenon Alexa Fluor
568 Mouse IgG1 labelling kit (Invitrogen). NMJ pictures were
obtained using a Leica automated brightﬁeld multi-colour epi-
ﬂuorescent microscope. Individual synapses were imaged and
the muscle area, NMJ area, perimeter, length, branching pattern
and amount of active zones were quantitatively assessed using
an inhouse developed macro.
Analysis of simj mRNA levels by real-time PCR
Total RNA from 3rd instar larvae was isolated using RNeasy
Lipid Tissue Mini Kit (Qiagen). RNA was treated with DNase
(DNAfree Kit, Ambion). First strand cDNA synthesis was per-
formed using the Moloney Murine Leukemia Virus (M-MLV)
Reverse Transcriptase (Life Technologies) and oligo(dT) primer.
Gene expression was analysed by real-time PCR (7900HT Fast
Real-Time PCR system, Applied Biosystems). PCR reactions were
performed in a volume of 25 ml containing 150 nM primers and
GoTag Green Mastermix (Promega). Primer sequences used for
ampliﬁcation of simj were 50-CAGCACCATTCCGTTGTG-30
(forward primer) and 50-GCCTTGAGTGCCTTCTTCAC-30
(reverse primer). A PolII amplicon was used as an internal stand-
ard. PolII primer sequences were 50-TCAGAGTCCGCGTAA
CACC-30 (forward primer) and 50-TGGTCACAAGTGGCTTCA
TC-30 (reverse primer).
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RESULTS
Clinical phenotype description
We here report the detailed clinical description of four affected
individuals. Individual 1 (ﬁgure 1A–D) was born after 36 weeks
and 5 days of pregnancy with a normal birth weight and no
major complications upon delivery. At 2 years of age, her parents
consulted a paediatrician because of global developmental delay.
She could sit and crawl at the age of 16 months and stand at the
age of 18 months. Hypotonia was noticed. After the age of
2 years she spoke her ﬁrst words. An ophthalmologist was con-
sulted because of strabismus. At the age of 3 years and 8 months
she was able to speak about 30 single words, but her comprehen-
sion of language was at a higher level. She had a normal height
(100 cm, 30th centile) and head circumference (47.5 cm, 10th
centile). Her facial features included thin blond hair, narrow pal-
pebral ﬁssures, periorbital fullness, a tubular shape of the nose
with full nasal tip, a short philtrum, thin upper lip, broad mouth
and grimacing facial expression. Three years later, at the age of
6 years and 7 months she had severe developmental delay with
verbal skills more severely impaired than motor skills. Her height
was normal (118.5 cm, 16th centile) and she had a low to
normal head circumference (48 cm, 2nd centile). Long ﬁngers
and toes with broad distal phalanges were observed.
Individual 2 (ﬁgure 1E–H) was born with intrauterine growth
retardation. Her birth weight was 2780 g at 42 weeks of preg-
nancy (<2nd centile). At 3 months of age a developmental
delay was noticed. She could walk independently at the age of
3 years. From 8 years on, she could speak single words.
Behaviour was characterised by tics and wandering during the
night. Her pain threshold was elevated. Vision was impaired
due to hypoplasia of the optic nerve. Upon clinical evaluation at
the age of 34 years she was diagnosed with severe ID. At that
time, height and head circumference were normal (both >16th
centile). She had thin blond hair, deeply set eyes, narrow and
upward slanting palpebral ﬁssures, strabismus, a tubular shape
of the nose with broad nasal tip, and a large mouth with short
philtrum and thin upper lip. She grimaced. Her ﬁngers were
long, thin and slightly tapering.
Individual 3 (ﬁgure 1I,J) was born after an uncomplicated
pregnancy of 40 weeks duration, with a low-normal birth weight
Figure 1 Facial features of individuals 1–4. Individual 1 at the age of 3 years and 8 months (A and B) and 6 years and 7 months (C and D). Individual
2 at the age of 5 years (E), at older childhood age (F) and at age 35 years (G and H). Individual 3 at the age of 3 years (I and J), and individual 4 at the
age of 12 years (M and N) and younger ages (K and L). Note the similarity in facial features, comprising thin, blond hair, broad forehead, hypertelorism,
periorbital fullness, deeply set eyes and narrow palpebral ﬁssures, a short philtrum, large, tubular shaped nose with broad nasal tip, broad mouth,
strabismus, and remarkable grimacing facial expression in individuals 1, 2 and 4. Access the article online to view this ﬁgure in colour.
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and a normal head circumference. In the neonatal period she pre-
sented with hypotonia and feeding difﬁculties. Her psychomotor
development was delayed. She learnt to walk without support at
the age of 2 years and 9 months. At the age of 3 years speech was
severely delayed with only two to three disyllabic words. Her
behaviour was characterised by low frustration tolerance.
Medical problems included hypermetropia and strabismus and
she had shown one episode of absence epilepsy. At the age of
3 years she had a height of 90 cm (5th centile), and a head cir-
cumference of 51 cm (84th centile). Facial dysmorphism
included hypertelorism, a broad forehead, a broad and ﬂat nasal
bridge and a full square tip of the nose. She had thin, blond hair.
Individual 4 (ﬁgure 1K–N) was born after 42 weeks of preg-
nancy with a normal birth weight. Birth was uncomplicated. She
was hypotonic and passive in the neonatal period. From the
beginning on, psychomotor development was delayed with poor
contact making. She learned to walk from the age of 2 years and
started to speak during her third year. Her speech slowly devel-
oped, and at the age of 12 years she could only speak six single
words. Her behaviour was characterised by hyperactivity,
inappropriate laughter, obsession for shiny and reﬂecting objects
and mild self-mutilation. Melatonin treatment was given for
sleep problems. Medical problems included intermittent diver-
gent strabismus and hypermetropic astigmatism, and persistent
constipation. Around the age of 2–3 years absence epilepsy was
suspected, but electroencephalography revealed no abnormal-
ities. Upon physical examination at the age of 12 years and
2 months she had a height of 156 cm (50th centile), a weight of
43 kg (16th–50th centile) and a head circumference of 56.2 cm
(80th–90th centile). Facial dysmorphism included a broad fore-
head, a broad nasal bridge with full nose tip, a broad mouth
with wide-spaced central incisors, short philtrum and long pal-
pebral ﬁssures. She had thin, blond hair. Her ﬁngers were long
and she had ﬂeshy hands.
Mutation detection
Individual 1 showed no abnormalities on 250K Singly
Nucleotide Polymorphism (SNP) array analysis, screening for
Fragile X syndrome, a metabolic screen in blood and urine, and
MRI imaging of the brain. Family based WES revealed a de
novo frameshift mutation in GATAD2B (c.584dup; p.
(Asn195fs); ﬁgure 2A). This mutation is located in the central
part of the gene close to the conserved region 1 (CR1) domain
(ﬁgure 2D).8 Likewise, individual 2 did not show any abnormal-
ity on 250K SNP array analysis and a metabolic screen.
Methylation tests of the Angelman syndrome related region
were normal. Family based exome sequencing revealed a de
novo mutation in GATAD2B (c.1408 C>T; p.(Gln470*); ﬁgure
2B). This mutation is located in the conserved region 2 (CR2)
domain (ﬁgure 2D).8
Figure 2 BAM ﬁles and results of Sanger sequencing in individuals 1, 2 and 4 and their parents. Validation and de novo testing for the candidate de
novo mutations in GATA zinc ﬁnger domain containing 2B (GATAD2B) in individuals 1 and 2, and direct sequencing of the 11 coding exons of GATAD2B
in the cohort of individuals with phenotypic overlap, including individual 4, were performed using standard Sanger sequencing approaches. Primer
sequences and PCR conditions are available upon request. (A and B) show the BAM ﬁles and the Sanger sequences of individuals 1 and 2, and (C)
Sanger sequences of individual 4. Sequences of both parents of individuals 1 and 2 and the mother of individual 4 are shown as well. The mother of
individual 4 carries the mutation in low mosaic state (<10%). (D) illustrates the relative positions of the mutations of individuals 1, 2 and 4 in the
GATAD2B protein. CR1, conserved region 1; CR2, conserved region 2. Access the article online to view this ﬁgure in colour.
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Individual 4 was previously investigated for mutations in the
genes FMR1, MECP2, TCF4, RAI1 and UBE3A, all showing
normal results. Methylation tests of the Angelman syndrome
related region and a metabolic screen gave also normal results.
Conventional G-banded karyotyping yielded a
maternally-inherited apparently balanced translocation between
chromosomes 1q21.3 and 9q13. Further 250K SNP array ana-
lysis did not show any imbalances of these regions. Targeted
sequencing of GATAD2B based on phenotypic overlap with the
ﬁrst two individuals led to the identiﬁcation of a frameshift muta-
tion (c.565_566del; p.(Gln190fs); ﬁgure 2C). This mutation is
located at the border of the CR1 domain (ﬁgure 2D). The
healthy mother carried the GATAD2B mutation in a low mosaic
level, which was estimated to be below 10% in peripheral blood
lymphocytes (ﬁgure 2C). The mother is highly educated and
works as a social worker. She has no facial dysmorphism.
Copy number variation detection
Array comparative genomic hybridisation (CGH) analysis in
individual 3 by a 60 K Agilent array, using the International
Standards for Cytogenomic Arrays (ISCA) design, revealed a
240 kb de novo deletion of chromosome 1q21.3 encompassing
10 genes, including GATAD2B (chr1 : 153 893 110–
154 132 780, Hg19). The distal breakpoint disrupts GATAD2B.
The deleted region encompasses no known disease associated
genes. The deletion was conﬁrmed by Fluorescent in situ
Hybridisation (FISH) with the RP11-422P24 probe. Segregation
analysis in the parents was done by FISH analysis and showed
that the deletion had occurred de novo.
Analysis of GATAD2B orthologue in Drosophila
To obtain independent evidence for the involvement of
GATAD2B in the ID phenotype of the described individuals, we
decided to study its function in an intact nervous system, using
Drosophila as a model. The Drosophila genome contains a
single orthologue of the two closely related human GATAD2A
and GATAD2B genes, named simjang (simj). Drosophila simj
has been shown to modify Wnt signalling and, like both its
human counterparts, to associate with the MeCP1-Mi-2–NuRD
repressor complex.14
Neuronal knockdown of Drosophila GATAD2B orthologue
results in impaired learning
Null mutations of Drosophila simj have previously been reported
to be lethal,14 which precluded assessment of cognitive function
in adult ﬂies. We therefore targeted expression of simj speciﬁcally
in Drosophila neurones using the UAS-Gal4 system in combin-
ation with inducible RNAi15 and examined the role of simj in
habituation. Habituation is a form of non-associative learning
where the probability of a behavioural response decreases with
repeated presentations of a stimulus.16 Habituation was previ-
ously shown to be defective in classic learning and memory
mutants and in a Drosophila model of ID.2 17 18
To induce a panneuronal knockdown of simj, ﬂies carrying an
inducible UAS-RNAi insertion against simj (vdrcKK100285)
were mated to ﬂies carrying the neuronal promoter element
elav-Gal4 driver. The promoter line further carried one copy of
UAS-dicer2 to enhance the RNAi-mediated knockdown and two
insertions of GMR-wIR to reduce the eye colour as required in
our assay. Male progeny of knockdown (simj-RNAi) and control
ﬂies was exposed to 100 short light-off stimuli (trials) at 1 s
inter-trial intervals and scored for a jump response. Flies were
considered to have habituated once they failed to jump in ﬁve
consecutive trials (no-jump criterion). Habituation was scored as
the number of trials required to reach the no-jump criterion
(TTC). Both genotypes showed wt-like initial jump responses.
Control ﬂies quickly habituated to the light-off stimuli and
reduced jumping. We found that simj-RNAi ﬂies habituate
slower and maintain a higher jump response throughout the
entire course of the experiment (ﬁgure 3A). The mean TTC of
simj-RNAi ﬂies was 1.7-fold higher compared with their genetic
background controls (ﬁgure 3B, p=0.007), validating a signiﬁ-
cant deﬁcit in habituation.
GATAD2B is required for synaptic development in
Drosophila
Synaptic connectivity is essential for learning and for other cog-
nitive processes.1 We therefore addressed a possible function of
simj in synaptic development of the larval NMJ, a well-
established synaptic model system that shares major features
with central excitatory synapses in the mammalian brain19 and
has been successfully used to investigate human ID disorders.20–22
As in our habituation experiment, we investigated the Drosophila
NMJ architecture upon panneuronal knockdown of simj. The syn-
aptic and subsynaptic organisation was visualised by coimmunola-
belling against dlg1 (α-dlg1), a major scaffolding component of
larval NMJs and member of the membrane-associated guanylate
kinase subfamily, and anti-brp (α-brp, nc82), an integral part of
active zones.22
Neurone-speciﬁc simj knockdown resulted in an NMJ under-
growth phenotype (ﬁgure 4A,B), with a consistent decrease in
synaptic area (p=0.0028), perimeter (p=9.5e−005) and length
Figure 3 Impaired habituation of neurone-speciﬁc knockdown of Drosophila GATA zinc ﬁnger domain containing 2B orthologue Simjang (simj).
Habituation was measured in simj knockdown (UAS-simjRNAi100285/2xGMR-wIR; elav-Gal4, UAS-Dicer2/+, red squares) and control males
(2xGMR-wIR/+; elav-Gal4, UAS-Dicer2/+, black circles). Jump response was induced by repeated light-off pulses for 100 trials with 1 s inter-trial
interval. y Axis represents the average jump response whereas x axis represents number of trials (A). Habituation was signiﬁcantly slower for simj
knockdown ﬂies (red bar, Trials To Criterion (TTC)=35.70) than for control ﬂies (black bars, TTC=21.17). (**) indicates a signiﬁcant difference
(p<0.01) based on one-way ANOVA (B). RNAi, RNA interference. Access the article online to view this ﬁgure in colour.
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(p=5.7e−008). Simj-RNAi synapses also exhibited a lower
number of branches (p=0.041) and branching points
(p=0.021). Last, simj-RNAi synapses showed a lower number
of active zones (p=0.001), revealing a reduced number of pre-
synaptic sites for neurotransmitter release. Muscle size was not
affected, which excludes a general growth/developmental
problem. We validated the potency of the used RNAi line to
induce simj knockdown by real-time PCR. The level of simj
mRNAwas efﬁciently downregulated to 29% upon induction by
a ubiquitous actin-Gal4 driver (p=0.0024; two-tailed t test). We
conclude that reduced levels of the GATAD2B orthologue simj
affect learning and synapse development.
DISCUSSION
In this study, we report a novel clinically recognisable syndrome
characterised by severe ID, limited speech, childhood hypotonia,
thin hair and recognisable facial features, including a typical,
tubular shaped nose with broad tip, deeply set eyes, broad fore-
head, short philtrum, broad mouth, grimacing facial expression,
strabismus and long ﬁngers caused by haploinsufﬁciency of
GATAD2B. We recently identiﬁed by family based exome
sequencing disruptive GATAD2B mutations in two individuals
with overlapping phenotype.8 We traced a third individual with
a small microdeletion encompassing GATAD2B showing a very
similar phenotype. Though we cannot fully exclude a contribu-
tion of the nine other genes in the deleted region of this individ-
ual, the important phenotypic overlap with individuals 1 and 2
highly suggests that deletion of GATAD2B is the major causal
factor in the phenotype of this individual. Moreover, this
further conﬁrms the role of GATAD2B in a recognisable syn-
drome with ID represented by the present individuals. To ultim-
ately further establish a novel ID syndrome, we selected a
cohort of 80 unsolved similarly affected individuals based on
clinical overlap. Targeted Sanger sequencing of the GATAD2B
locus revealed an additional patient carrying a frameshift
GATAD2B mutation, presumably causing loss-of-function.
We noticed that GATAD2B is located in the chromosomal
region 1q21.3 where the breakpoint of the balanced transloca-
tion that was previously found in individual 4 and her healthy
mother is also located. Although this ﬁnding might be coinci-
dental, it raised the question whether the mother carried a
mosaic translocation and whether the translocation breakpoint
predisposed to the deletion of two base pairs in GATAD2B. We
therefore performed additional FISH analysis with the region
1q23.1 speciﬁc probe RP11-216N14 that covers the GATAD2B
gene. This showed in all 29 evaluated cells a normal pattern,
indicating that the translocation breakpoint is located distally
from the GATAD2B region. Therefore, we concluded that this
does not support a correlation between the mutation in
GATAD2B and the balanced translocation.
Complementary functional studies of the Drosophila
GATAD2B orthologue simj demonstrated a role for the evolu-
tionarily conserved GATAD2B gene family in neurodevelopmen-
tal processes. The identiﬁed habituation defect in simj-RNAi
ﬂies demonstrates that the GATAD2B orthologue is required for
non-associative learning. Furthermore, evaluation of synaptic
morphology revealed an NMJ undergrowth phenotype with
reduced number of active zones, suggesting a critical role for
simj and GATAD2B in synaptic growth and function. Whether
these may contribute to or cause the observed learning defects
in ﬂies and cognitive deﬁcit in the humans remains to be
determined.
Mutations in several recently identiﬁed genes involved in
chromatin modiﬁcation give rise to ID syndromes, such as the
17q21.31 microdeletion/Koolen-De Vries syndrome (KDVS
(MIM 610443)),23 24 Cofﬁn-Siris syndrome13 25 (CSS
(MIM135900)), Nicolaides-Baraitser syndrome26 27 (NCBRS
(MIM 601358)), Kleefstra syndrome2 28 (MIM 610253),
Wiedemann-Steiner syndrome29 (WDSTS (MIM 605130)) and
Ohdo syndrome Say-Barber-Biesecker variant30 (SBBYSS (MIM
603736).
GATAD2B encodes p66beta, which is a subunit of the tran-
scription repressor complex MeCP1-Mi2–NuRD that silences
methylated DNA by nucleosome remodelling and histone deace-
tylation. This enzyme complex also comprises its close paralo-
gue p66alpha (encoded by GATAD2A), the histone deacetylases
HDAC1 and HDAC2, two histone binding proteins RbAp46
and RbAp48, the methyl binding domain protein 3 (MBD3),
two histone modiﬁer proteins, MTA1 and MTA2, and nucleo-
some remodelling factor Mi-2.11 It is thus conceivable that add-
itional genes from the MeCP1-Mi2–NuRD complex, such as
GATAD2A, are involved in phenotypes overlapping with the
here deﬁned novel syndrome caused by GATAD2B mutations.
P66beta and its paralogue, p66alpha, function synergistically
and recruit the Mi-2–NuRD complex to its target sites.
They interact with methyl-CpG bound MBD2 and with
Figure 4 Synapse morphology of neuromuscular junctions (NMJs) was studied in Simjang (simj) knockdown ﬂies (UAS-simjRNAi100285/UAS-Dicer2;
elav-Gal4/+) (A). NMJs were visualised with coimmunolabelling against discs large 1 (A, upper panel) and brp (A, middle panel) and quantitatively
assessed by computer-assisted analysis (A, lower panel and B). Simj-RNA interference (RNAi) NMJs show a decrease in NMJ area (n=27, p=0.0028),
perimeter (n=27, p=9.5e−005), length (n=28, p=5.7e−008), the amount of branches (n=28, p=0.041) and branching points (n=28, p=0.021) and the
amount of active zones (n=25, p=0.0010). The area of the muscle remained normal (n=28, p=0.077). For this plot, red bars represent the mean of
each parameter of Simj-RNAi NMJs normalised by the mean of each parameter of the control set (black bars). Error bars indicate the normalised
standard error of the mean, p, p values (two-sided t test); n, number of quantiﬁed NMJs. (*) indicates a signiﬁcant difference (p<0.05), (**)
indicates a signiﬁcant difference (p<0.01), (***) indicates a signiﬁcant difference (p<0.001). Access the article online to view this ﬁgure in colour.
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non-acetylated histones to assemble in the so-called MeCP1
repressor complex.11 It has been shown that p66alpha and
p66beta, and particularly their highly conserved CR1 and CR2
domains, are crucial for complex formation and mediated gene
silencing.12 Furthermore, homozygous loss-of-function of
p66alpha in mice resulted in an embryonic lethal phenotype
with severe global malformations, growth retardation and necro-
sis. Heterozygous mice were viable and appeared normal, but
detailed (neurological) phenotyping was not performed.31
We recently used the powerful strategy of combining human
genetic studies and Drosophila modelling to provide a novel
chromatin remodelling module that underlies Kleefstra syn-
drome spectrum.2 Similar to that, we ﬁnd a strikingly high con-
servation between human and Drosophila NuRD complexes,
with all complex components being present in ﬂy.32 As add-
itional variants in human NuRD complex genes will arise, it
will be straightforward to validate their signiﬁcance. Our data
add GATAD2B, and possibly the whole MeCP1-Mi2–NuRD
complex, to the growing list of ID genes involved in chromatin
remodelling.
Author afﬁliations
1Department of Human Genetics, Radboud University Medical Centre, Nijmegen,
The Netherlands
2Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre,
Nijmegen, The Netherlands
3Donders Institute for Brain, Cognition and Behavior, Radboud University Medical
Centre, Nijmegen, The Netherlands
4Department of Genetics, Aktogen, University of Cambridge, Cambrigde, UK
5Institute of Biochemistry, Biological Research Center, Hungarian Academy of
Sciences, Szeged, Hungary
6Institute for Genetic and Metabolic Disease, Radboud University Medical Centre,
Nijmegen, The Netherlands
7Service de Génétique Médicale, CHU Nantes, Nantes, France
8Service de Pédiatrie, CHU Nantes, Nantes, France
9Aktogen Hungary Ltd., Biological Research Center, Hungarian Academy of Sciences,
Szeged, Hungary
Acknowledgements We thank the participating individuals and their families. We
also thank Suzanne Vloet-Keijzer and Martine Ruiterkamp for their technical
assistance with the targeted Sanger sequencing.
Contributors The study was designed and the results were interpreted by MHW,
TK, BN, MF, ZA, LA, AC-N, EV, AS, LELMV, HGB, HvB and JAV. Subject
ascertainment and recruitment were carried out by MHW, TK, BWMvB, DAK,
EMHFB, BI, CLC, EL and BBAdV. Sequencing and genotyping were carried out and
interpreted by WMN, HGY, LELMV, JdL and JAV. The manuscript was drafted by
MHW, BN, MF, TK and AS. All authors contributed to the ﬁnal version of the paper.
Funding This work was supported by grants from the Consortium ‘Stronger on your
own feet’ to TK and MHW, The Netherlands Organization for Health Research and
Development (ZonMw grants 917-86-319 to BBAdV, 916-86-016 to LELMV,
917-96-346 to AS and 907-00-365 to TK), the European Union under the 7th
framework program (Gencodys HEALTH-F4-2010-241995 to BBAdV, HvB, ZA, AS
and TK), the Dutch Brain Foundation (to DAK and BBAdV), the Hungarian Scientiﬁc
Research Fund (K-82090 to ZA), and grants from the Jérôme Lejeune foundation
and from the German Federal Ministry of Education and Research (BMBF funding to
the German Mental Retardation Network, MRNET to AS).
Competing interests None.
Patient consent Obtained.
Ethics approval Local medical ethical committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Web resources http://decipher.sanger.ac.uk; http://www.ecaruca.net
REFERENCES
1 van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Ann
Rev Genet 2011;45:81–104.
2 Kleefstra T, Kramer JM, Neveling K, Willemsen MH, Koemans TS, Vissers LE,
Wissink-Lindhout W, Fenckova M, van den Akker WM, Kasri NN, Nillesen WM,
Prescott T, Clark RD, Devriendt K, van Reeuwijk J, de Brouwer AP, Gilissen C,
Zhou H, Brunner HG, Veltman JA, Schenck A, van Bokhoven H. Disruption of an
EHMT1-associated chromatin-modiﬁcation module causes intellectual disability. Am
J Hum Genet 2012;91:73–82.
3 Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI,
Beck AE, Tabor HK, Cooper GM, Mefford HC, Lee C, Turner EH, Smith JD,
Rieder MJ, Yoshiura K, Matsumoto N, Ohta T, Niikawa N, Nickerson DA,
Bamshad MJ, Shendure J. Exome sequencing identiﬁes MLL2 mutations as a cause
of Kabuki syndrome. Nat Genet 2010;42:790–3.
4 Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M, de Vries P,
de Reuver R, Wieskamp N, Mortier G, Devriendt K, Amorim MZ, Revencu N,
Kidd A, Barbosa M, Turner A, Smith J, Oley C, Henderson A, Hayes IM,
Thompson EM, Brunner HG, de Vries BB, Veltman JA. De novo mutations of
SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010;42:483–5.
5 Hoischen A, van Bon BW, Rodriguez-Santiago B, Gilissen C, Vissers LE, de Vries P,
Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S,
Goodship J, McGowan R, Bartholdi D, Rauch A, Peippo M, Cobben JM, Wieczorek D,
Gillessen-Kaesbach G, Veltman JA, Brunner HG, de Vries BB. De novo nonsense
mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 2011;43:729–31.
6 Sirmaci A, Spiliopoulos M, Brancati F, Powell E, Duman D, Abrams A, Bademci G,
Agolini E, Guo S, Konuk B, Kavaz A, Blanton S, Digilio MC, Dallapiccola B,
Young J, Zuchner S, Tekin M. Mutations in ANKRD11 cause KBG syndrome,
characterized by intellectual disability, skeletal malformations, and macrodontia. Am
J Hum Genet 2011;89:289–94.
7 Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B,
Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB,
Brunner HG, Veltman JA. A de novo paradigm for mental retardation. Nat Genet
2010;42:1109–12.
8 de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van
Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A,
Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. Diagnostic exome
sequencing in persons with severe intellectual disability. N Engl J Med
2012;367:1921–9.
9 Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B,
Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J,
Joset P, Röpke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E,
Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A,
Engels H, Rappold G, Schröck E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM.
Range of genetic mutations associated with severe non-syndromic sporadic
intellectual disability: an exome sequencing study. Lancet 2012;380:1674–82.
10 Willemsen MH, Vissers LE, Willemsen MA, van Bon BW, Kroes T, de Ligt J, de
Vries BB, Schoots J, Lugtenberg D, Hamel BC, van Bokhoven H, Brunner HG,
Veltman JA, Kleefstra T. Mutations in DYNC1H1 cause severe intellectual disability
with neuronal migration defects. J Med Genet 2012;49:179–83.
11 Feng Q, Zhang Y. The MeCP1 complex represses transcription through preferential
binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev
2011;15:827–32.
12 Brackertz M, Gong Z, Leers J, Renkawitz R. p66alpha and p66beta of the Mi-2/
NuRD complex mediate MBD2 and histone interaction. Nucl Acids Res
2006;34:397–406.
13 Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T,
Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y,
Yamagata T, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K,
Ohta T, Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N,
Matsumoto N. Mutations affecting components of the SWI/SNF complex cause
Cofﬁn-Siris syndrome. Nat Genet 2012;44:376–8.
14 Kon C, Cadigan KM, da Silva SL, Nusse R. Developmental roles of the Mi-2/
NURD-associated protein p66 in Drosophila. Genetics 2005;169:2087–100.
15 Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M, Gasser B, Kinsey K,
Oppel S, Scheiblauer S, Couto A, Marra V, Keleman K, Dickson BJ. A genome-wide
transgenic RNAi library for conditional gene inactivation in Drosophila. Nature
2007;448:151–6.
16 Sharma P, Keane J, O’Kane CJ, Asztalos Z. Automated measurement of Drosophila
jump reﬂex habituation and its use for mutant screening. J Neurosci Meth
2009;182:43–8.
17 Asztalos Z, Arora N, Tully T. Olfactory jump reﬂex habituation in Drosophila and
effects of classical conditioning mutations. J Neurogenet 2007;21:1–18.
18 Kramer JM, Kochinke K, Oortveld MA, Marks H, Kramer D, de Jong EK, Asztalos Z,
Westwood JT, Stunnenberg HG, Sokolowski MB, Keleman K, Zhou H, van
Bokhoven H, Schenck A. Epigenetic regulation of learning and memory by
Drosophila EHMT/G9a. PLoS Biol 2011;9:e1000569.
19 Koh YH, Gramates LS, Budnik V. Drosophila larval neuromuscular junction:
molecular components and mechanisms underlying synaptic plasticity. Microsc Res
Tech 2000;49:14–25.
20 Liu Z, Huang Y, Zhang Y, Chen D, Zhang YQ. Drosophila Acyl-CoA synthetase
long-chain family member 4 regulates axonal transport of synaptic vesicles and is
required for synaptic development and transmission. J Neurosci 2011;31:2052–63.
21 Schenck A, Bardoni B, Langmann C, Harden N, Mandel JL, Giangrande A. CYFIP/
Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase
pathway to the fragile X protein. Neuron 2003;38:887–98.
Willemsen MH, et al. J Med Genet 2013;50:507–514. doi:10.1136/jmedgenet-2012-101490 513
New disease loci
group.bmj.com on May 23, 2016 - Published by http://jmg.bmj.com/Downloaded from 
22 Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, Collins AL, Bijlsma EK,
Oortveld MA, Ekici AB, Reis A, Schenck A, Rauch A. CNTNAP2 and NRXN1 are
mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine
the level of a common synaptic protein in Drosophila. Am J Hum Genet
2009;85:655–66.
23 Koolen DA, Kramer JM, Neveling K, Nillesen WM, Moore-Barton HL, Elmslie FV,
Toutain A, Amiel J, Malan V, Tsai AC, Cheung SW, Gilissen C, Verwiel ET,
Martens S, Feuth T, Bongers EM, de Vries P, Scheffer H, Vissers LE, de Brouwer AP,
Brunner HG, Veltman JA, Schenck A, Yntema HG, de Vries BB. Mutations in the
chromatin modiﬁer gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat
Genet 2012;44:639–41.
24 Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJ, Goldenberg A, Saugier-Veber P,
Pfundt R, Vissers LE, Destrée A, Grisart B, Rooms L, Van der Aa N, Field M,
Hackett A, Bell K, Nowaczyk MJ, Mancini GM, Poddighe PJ, Schwartz CE, Rossi E, De
Gregori M, Antonacci-Fulton LL, McLellan MD II, Garrett JM, Wiechert MA, Miner TL,
Crosby S, Ciccone R, Willatt L, Rauch A, Zenker M, Aradhya S, Manning MA,
Strom TM, Wagenstaller J, Krepischi-Santos AC, Vianna-Morgante AM, Rosenberg C,
Price SM, Stewart H, Shaw-Smith C, Brunner HG, Wilkie AO, Veltman JA, Zuffardi O,
Eichler EE, de Vries BB. Clinical and molecular delineation of the 17q21.31
microdeletion syndrome. J Med Genet 2008;45:710–20.
25 Santen GW, Aten E, Sun Y, Almomani R, Gilissen C, Nielsen M, Kant SG,
Snoeck IN, Peeters EA, Hilhorst-Hofstee Y, Wessels MW, den Hollander NS,
Ruivenkamp CA, van Ommen GJ, Breuning MH, den Dunnen JT, van Haeringen A,
Kriek M. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause
Cofﬁn-Siris syndrome. Nat Genet 2012;44:379–80.
26 Van Houdt JK, Nowakowska BA, Sousa SB, van Schaik BD, Seuntjens E, Avonce N,
Sifrim A, Abdul-Rahman OA, van den Boogaard MJ, Bottani A, Castori M,
Cormier-Daire V, Deardorff MA, Filges I, Fryer A, Fryns JP, Gana S, Garavelli L,
Gillessen-Kaesbach G, Hall BD, Horn D, Huylebroeck D, Klapecki J,
Krajewska-Walasek M, Kuechler A, Lines MA, Maas S, Macdermot KD, McKee S,
Magee A, de Man SA, Moreau Y, Morice-Picard F, Obersztyn E, Pilch J, Rosser E,
Shannon N, Stolte-Dijkstra I, Van Dijck P, Vilain C, Vogels A, Wakeling E,
Wieczorek D, Wilson L, Zuffardi O, van Kampen AH, Devriendt K, Hennekam R,
Vermeesch JR. Heterozygous missense mutations in SMARCA2 cause
Nicolaides-Baraitser syndrome. Nat Genet 2012;44:445–9.
27 Wolff D, Endele S, Azzarello-Burri S, Hoyer J, Zweier M, Schanze I, Schmitt B,
Rauch A, Reis A, Zweier C. In-frame deletion and missense mutations of the
C-terminal helicase domain of SMARCA2 in three patients with Nicolaides-Baraitser
Syndrome. Mol Syndromol 2012;6:237–44.
28 Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A,
Geneviève D, Cormier-Daire V, van Esch H, Fryns JP, Hamel BC, Sistermans EA, de
Vries BB, van Bokhoven H. Loss-of-function mutations in euchromatin histone
methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am
J Hum Genet 2006;79:370–7.
29 Jones WD, Dafou D, McEntagart M, Woollard WJ, Elmslie FV, Holder-Espinasse M,
Irving M, Saggar AK, Smithson S, Trembath RC, Deshpande C, Simpson MA. De
novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet
2012;91:358–64.
30 Clayton-Smith J, O’Sullivan J, Daly S, Bhaskar S, Day R, Anderson B, Voss AK,
Thomas T, Biesecker LG, Smith P, Fryer A, Chandler KE, Kerr B, Tassabehji M,
Lynch SA, Krajewska-Walasek M, McKee S, Smith J, Sweeney E, Mansour S,
Mohammed S, Donnai D, Black G. Whole-exome-sequencing identiﬁes mutations in
histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker
variant of Ohdo syndrome. Am J Hum Genet 2011;89:675–81.
31 Marino S, Nusse R. Mutants in the mouse NuRD/Mi2 component P66alpha are
embryonic lethal. Plos ONE 2007;2:e519.32.
32 Marhold J, Brehm A, Kramer K. The Drosophila methyl-DNA binding protein MBD2/
3 interacts with the NuRD complex via p55 and MI-2. BMC Mol Biol 2004;5:20.
514 Willemsen MH, et al. J Med Genet 2013;50:507–514. doi:10.1136/jmedgenet-2012-101490
New disease loci
group.bmj.com on May 23, 2016 - Published by http://jmg.bmj.com/Downloaded from 
